precision therapeutics

 

In today’s life science and biopharmaceutical industries the challenge of manual processes with little or no automation coupled with critical compliance requirements has a direct correlation to the high rates of failure and high cost of therapy manufacturing.

Current systems are siloed with disjointed multi-vendor IT systems and bio-process equipment. It’s extremely challenging to create an automated and validated environment for biologics manufacturing with a heterogeneous environment of paper, software systems, instruments, environmental monitoring systems, and bio-process equipment.

L7’s ESP is a unique regulatory compliant platform that provides an integrated software platform for cell and gene therapy companies with various features including EBR, MES, CPV, inventory, sample/ location management, and analytics/statistical processing with reports and dashboard and LIMS. ESP is a single validated software solution that automates the entire multi-day manufacturing process and quality control.

ESP provides real-time monitoring of samples with integration to instruments, process equipment, EMS, QMS and ERP systems.

Visibility

CTOs, Manufacturing and CMC leaders can use ESP to gain visibility to assess operational performance, long term planning needs, and state of regulatory compliance and business goals.

Integration

Heads of supply chain, clinical operations, and process development benefit from ESP’s data integration across the full therapeutic value chain to understand cycle times, delivery performance, capacity bottlenecks, and resource allocations.

Collaboration

Directors of quality control, manufacturing, and process development use ESP to quickly streamline data exchange across functions, improving the access to data across teams to improve team performance and deliver on critical milestones.

L7 ESP for precision therapeutics

key benefits

BENEFIT 1

ESP provides single data and process automation platform for all therapy-related information in regulatory compliant way that supports better collaboration between all the stakeholders.

BENEFIT 2

ESP links disparate systems with connectors to existing systems, apps to view same data from one system and interfaces with analytics tools.

BENEFIT 3

ESP is easy to implement and user driven, no rip and replace of existing systems.

pharma and bio-tech workflow

legacy data and process silos continue to exist

hinders efficiency and science, increases risk for business and patient

 

white papers

L7 and Gradalis

value proposition

ESP can serve as a data slipstream for manufacturing, process, and QC data thereby improving quality, reducing redundancies, and enhancing visibility across stakeholders thereby strengthening the understanding between process, product, and clinical outcomes.

clients

white papers/case studies

L7 Informatics and Gradalis

LIMS MIGRATION STRATEGY

WHITE PAPER: 5 STRATEGIES TO IMPROVE LAB EFFICIENCY

L7 Informatics and Gradalis

LIMS MIGRATION STRATEGY

WHITE PAPER: 5 STRATEGIES TO IMPROVE LAB EFFICIENCY

L7 Informatics and Gradalis

LIMS MIGRATION STRATEGY

WHITE PAPER: 5 STRATEGIES TO IMPROVE LAB EFFICIENCY

L7 in the news

COVID-19, A Letter to Our Valued Partners

USDA-USMARC Streamlines Research Operations with L7 Informatics NGS LIMS System

Software and Analytics Company to Deploy Cutting Edge Platform for Leading Fertility Organization

Inari Agriculture Selects L7 Informatics’ Enterprise Science Platform to Unify Global Operations

G-CON Manufacturing and L7 Informatics Announce a Collaboration to Develop ESP G-CON smartPOD, the First-of-its-Kind Integrated Cleanroom Software Platform

Rethinking Data Management to Accelerate Discoveries in Life Sciences

GRADALIS DEPLOYS L7’S ENTERPRISE SCIENCE PLATFORM FOR NEXT-GENERATION LIFE SCIENCE COMPANIES IN RECORD TIME TO SUPPORT MISSION-CRITICAL IMMUNOTHERAPY MANUFACTURING AND CLINICAL TRIAL PROCESSES

L7 INFORMATICS RELEASES L7 ENTERPRISE SCIENCE PLATFORM 2.0 WITH PRE-BUILT MICROSOFT GENOMICS INTEGRATION

Lab7 Systems Appoints New CEO and Changes Name to L7 Informatics

COVID-19, A Letter to Our Valued Partners

USDA-USMARC Streamlines Research Operations with L7 Informatics NGS LIMS System

Software and Analytics Company to Deploy Cutting Edge Platform for Leading Fertility Organization

Inari Agriculture Selects L7 Informatics’ Enterprise Science Platform to Unify Global Operations

G-CON Manufacturing and L7 Informatics Announce a Collaboration to Develop ESP G-CON smartPOD, the First-of-its-Kind Integrated Cleanroom Software Platform

Rethinking Data Management to Accelerate Discoveries in Life Sciences

GRADALIS DEPLOYS L7’S ENTERPRISE SCIENCE PLATFORM FOR NEXT-GENERATION LIFE SCIENCE COMPANIES IN RECORD TIME TO SUPPORT MISSION-CRITICAL IMMUNOTHERAPY MANUFACTURING AND CLINICAL TRIAL PROCESSES

L7 INFORMATICS RELEASES L7 ENTERPRISE SCIENCE PLATFORM 2.0 WITH PRE-BUILT MICROSOFT GENOMICS INTEGRATION

COVID-19, A Letter to Our Valued Partners

USDA-USMARC Streamlines Research Operations with L7 Informatics NGS LIMS System

USDA-USMARC Streamlines Research Operations with L7 Informatics NGS LIMS System

Software and Analytics Company to Deploy Cutting Edge Platform for Leading Fertility Organization

Inari Agriculture Selects L7 Informatics’ Enterprise Science Platform to Unify Global Operations

G-CON Manufacturing and L7 Informatics Announce a Collaboration to Develop ESP G-CON smartPOD, the First-of-its-Kind Integrated Cleanroom Software Platform

Rethinking Data Management to Accelerate Discoveries in Life Sciences

GRADALIS DEPLOYS L7’S ENTERPRISE SCIENCE PLATFORM FOR NEXT-GENERATION LIFE SCIENCE COMPANIES IN RECORD TIME TO SUPPORT MISSION-CRITICAL IMMUNOTHERAPY MANUFACTURING AND CLINICAL TRIAL PROCESSES

L7 INFORMATICS RELEASES L7 ENTERPRISE SCIENCE PLATFORM 2.0 WITH PRE-BUILT MICROSOFT GENOMICS INTEGRATION

get in touch

Let’s work together to solve your workflow challenges.